Literature DB >> 16421665

Analysis of dissolution data using modified versions of Noyes-Whitney equation and the Weibull function.

Aristides Dokoumetzidis1, Vasiliki Papadopoulou, Panos Macheras.   

Abstract

PURPOSE: The aim of the study is to develop modified, branched versions of the Noyes-Whitney and the Weibull equations, including explicitly the solubility/dose parameter, for the analysis of dissolution data, which reach the plateau either at infinite or finite time.
METHODS: The modified Weibull function is applied to the analysis of experimental and literature dissolution data. To demonstrate the usefulness of the mathematical models, two model drugs are used: one highly soluble, metoprolol, and one relatively insoluble, ibuprofen.
RESULTS: The models were fitted successfully to the data performing better compared with their classic versions. The advantages of the use of the models presented are several. They fit better to a large range of datasets, especially for fast dissolution curves that reach complete dissolution at a finite time. Also, the modified Weibull presented can be derived from differential equations, and it has a physical meaning as opposed to the purely empirical character of the original Weibull equation. The exponent of the Weibull equation can be attributed to the heterogeneity of the process and can be explained by fractal kinetics concepts. Also, the solubility/dose ratio is present explicitly as a parameter and allows to obtain estimates of the solubility even when the dissolution data do not reach the solubility level.
CONCLUSION: The use of the developed branched equations gives better fittings and specific physical meaning to the dissolution parameters. Also, the findings underline the fact that even in the simplest, first-order case, the speed of the dissolution process depends on the dose, a fact of great importance in biopharmaceutic classification for regulatory purposes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16421665     DOI: 10.1007/s11095-006-9093-3

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  Does the dose-solubility ratio affect the mean dissolution time of drugs?

Authors:  P Lánský; M Weiss
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

Review 2.  Modeling and comparison of dissolution profiles.

Authors:  P Costa; J M Sousa Lobo
Journal:  Eur J Pharm Sci       Date:  2001-05       Impact factor: 4.384

3.  The mean dissolution time depends on the dose/solubility ratio.

Authors:  Eleni Rinaki; Aristides Dokoumetzidis; Panos Macheras
Journal:  Pharm Res       Date:  2003-03       Impact factor: 4.200

4.  Classification of dissolution profiles in terms of fractional dissolution rate and a novel measure of heterogeneity.

Authors:  Petr Lánský; Michael Weiss
Journal:  J Pharm Sci       Date:  2003-08       Impact factor: 3.534

5.  A stochastic differential equation model for drug dissolution and its parameters.

Authors:  Petr Lánský; Vera Lánská; Michael Weiss
Journal:  J Control Release       Date:  2004-11-24       Impact factor: 9.776

6.  Identification of biowaivers among Class II drugs: theoretical justification and practical examples.

Authors:  Eleni Rinaki; Aristides Dokoumetzidis; Georgia Valsami; Panos Macheras
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

7.  Fractal reaction kinetics.

Authors:  R Kopelman
Journal:  Science       Date:  1988-09-23       Impact factor: 47.728

8.  On methods of expressing dissolution rate data.

Authors:  J A Goldsmith; N Randall; S D Ross
Journal:  J Pharm Pharmacol       Date:  1978-06       Impact factor: 3.765

9.  Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets.

Authors:  J E Polli; G S Rekhi; L L Augsburger; V P Shah
Journal:  J Pharm Sci       Date:  1997-06       Impact factor: 3.534

10.  Linearization of dissolution rate curves by the Weibull distribution.

Authors:  F Langenbucher
Journal:  J Pharm Pharmacol       Date:  1972-12       Impact factor: 3.765

View more
  13 in total

1.  Development of a new method to assess nanocrystal dissolution based on light scattering.

Authors:  Katharina Anhalt; Simon Geissler; Meike Harms; Markus Weigandt; Gert Fricker
Journal:  Pharm Res       Date:  2012-06-12       Impact factor: 4.200

2.  Fabrication of triple-layer matrix tablets of venlafaxine hydrochloride using xanthan gum.

Authors:  Mukesh C Gohel; Shital H Bariya
Journal:  AAPS PharmSciTech       Date:  2009-05-15       Impact factor: 3.246

3.  Conversion of nanosuspensions into dry powders by spray drying: a case study.

Authors:  Mahesh V Chaubal; Carmen Popescu
Journal:  Pharm Res       Date:  2008-05-29       Impact factor: 4.200

4.  The changing face of the rate concept in biopharmaceutical sciences: from classical to fractal and finally to fractional.

Authors:  Aristides Dokoumetzidis; Panos Macheras
Journal:  Pharm Res       Date:  2011-01-25       Impact factor: 4.200

5.  Statistical comparison of dissolution profiles to predict the bioequivalence of extended release formulations.

Authors:  J D Gomez-Mantilla; U F Schaefer; V G Casabo; T Lehr; C M Lehr
Journal:  AAPS J       Date:  2014-05-23       Impact factor: 4.009

Review 6.  In vitro-in vivo correlation: perspectives on model development.

Authors:  Ying Lu; Sungwon Kim; Kinam Park
Journal:  Int J Pharm       Date:  2011-01-13       Impact factor: 5.875

Review 7.  Physiologically Based Pharmacokinetics Modeling in Biopharmaceutics: Case Studies for Establishing the Bioequivalence Safe Space for Innovator and Generic Drugs.

Authors:  Di Wu; Maitri Sanghavi; Sivacharan Kollipara; Tausif Ahmed; Anuj K Saini; Tycho Heimbach
Journal:  Pharm Res       Date:  2022-07-15       Impact factor: 4.580

8.  Impact of Formulation Parameters on In Vitro Release from Long-Acting Injectable Suspensions.

Authors:  Quanying Bao; Yuan Zou; Yan Wang; Stephanie Choi; Diane J Burgess
Journal:  AAPS J       Date:  2021-03-11       Impact factor: 4.009

9.  Formulation and particle size reduction improve bioavailability of poorly water-soluble compounds with antimalarial activity.

Authors:  Hongxing Wang; Qigui Li; Sean Reyes; Jing Zhang; Lisa Xie; Victor Melendez; Mark Hickman; Michael P Kozar
Journal:  Malar Res Treat       Date:  2013-05-12

10.  Formulation and Evaluation of Propranolol Hydrochloride-Loaded Carbopol-934P/Ethyl Cellulose Mucoadhesive Microspheres.

Authors:  Jayvadan Patel; Darshna Patel; Jignyasha Raval
Journal:  Iran J Pharm Res       Date:  2010       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.